Brief: Milestone Pharmaceuticals enters open market sale agreement with Jefferies
18/03/2025 21:51
March 18 (Reuters) - Milestone Pharmaceuticals Inc MIST.O: MILESTONE PHARMACEUTICALS INC - ENTERS AMENDED AND RESTATED OPEN MARKET SALE AGREEMENT WITH JEFFERIES - SEC FILING MILESTONE PHARMACEUTICALS INC - AGREEMENT ALLOWS SALE OF COMMON SHARES UP TO $77.8 MILLION - SEC FILING Source text: [ID:n0001104659-25-025055] Further company coverage: MIST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview